Yara Buisman
YOU?
Author Swipe
View article: Prognostic Significance of Measurable Residual Disease Detection by Flow Cytometry in Autologous Stem Cell Apheresis Products in AML
Prognostic Significance of Measurable Residual Disease Detection by Flow Cytometry in Autologous Stem Cell Apheresis Products in AML Open
Acute myeloid leukemia (AML) is a heterogeneous disease both in terms of genetics and clinical outcome.1 Patients can be subdivided into 3 risk groups using the European LeukemiaNet (ELN) prognostic risk classification with significantly d…
View article: P448: PROGNOSTIC SIGNIFICANCE OF MEASURABLE RESIDUAL DISEASE DETECTION BY FLOW CYTOMETRY IN AUTOLOGOUS STEM CELL APHERESIS PRODUCTS OF PATIENTS WITH AML
P448: PROGNOSTIC SIGNIFICANCE OF MEASURABLE RESIDUAL DISEASE DETECTION BY FLOW CYTOMETRY IN AUTOLOGOUS STEM CELL APHERESIS PRODUCTS OF PATIENTS WITH AML Open
Background: Measurable residual disease (MRD) detected by multiparameter flow cytometry (MFC) in bone marrow (BM) after two cycles of high-dose induction chemotherapy has strong prognostic value and predicts relapse when applied to patient…